Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
Barski
Peter R
PR
D000897:Anti-Ulcer Agents / Q000191:economics* / Q000627:therapeutic use; D001241:Aspirin / Q000191:economics* / Q000627:therapeutic use; D000077144:Clopidogrel; D017046:Cost Savings; D004359:Drug Therapy, Combination; D005252:Fees, Pharmaceutical; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000191:economics* / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin